T1	Participants 82 116	WHO type I anovulation infertility
T2	Participants 313 376	(WHO) Group I anovulation, or hypogonadotropic hypogonadism (HH
T3	Participants 749 762	women with HH
T4	Participants 885 1041	Eighteen patients received 150 IU hMG-HP (150 IU FSH + 150 IU LH-like activity) and seventeen received 150IU r-hFSH/75IU rhLH daily for a maximum of 16 days
T5	Participants 1864 1875	in HH women
